CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- 4 Open-market sale President and CEO sold 6,500 shares at an average $44.74 ($290,779)
- 4 Open-market sale Chief Financial Officer sold 252 shares at $50.04 ($12,610)
- 4 Open-market sale Chief Oper. & Tech. Officer sold 13,312 shares at an average $50.01 ($665,767)
- 4 Open-market sale Chief Financial Officer sold 15,293 shares at an average $50.02 ($765,025)
- 4 Open-market sale Chief Legal Officer sold 21,500 shares at an average $48.14 ($1,035,082)
- 4 Open-market sale Chief Oper. & Tech. Officer sold 5,185 shares at $50.01 ($259,302)
- 4 Open-market sale Chief Financial Officer sold 16,239 shares at an average $49.06 ($796,615)
- 4 Open-market sale President and CEO sold 1,500 shares at $50.01 ($75,015)
- 4 Grant or award Chief Financial Officer acquired 12,400 shares (grant or award)
- 4 Grant or award Chief Oper. & Tech. Officer acquired 13,800 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 11,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 12,543 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 13,800 shares (grant or award)
- 4 Grant or award President and CEO acquired 40,984 shares (grant or award)
- 4 Open-market sale President and CEO sold 6,500 shares at an average $48.67 ($316,334)
- 4 Open-market sale Chief Financial Officer sold 24,500 shares at an average $50.01 ($1,225,211)
- 4 Open-market sale President and CEO sold 4,500 shares at $50.00 ($225,000)
- 4 Open-market sale President and CEO sold 15,000 shares at $45.00 ($675,000)
- 4 Open-market sale Chief Financial Officer sold 37,500 shares at an average $40.10 ($1,503,891)
- 4 Open-market sale President and CEO sold 4,500 shares at $40.00 ($180,000)
Page 9 of 22 · 435 filings